TNF Pharmaceuticals, Inc.
TNFA
$0.135
-$0.002-1.46%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.12M | -2.06M | -1.93M | -9.57M | -9.80M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -1.20M | 710.30K | 381.50K | 6.66M | 7.55M |
| Change in Net Operating Assets | -315.60K | 589.80K | -2.08M | 240.40K | 491.80K |
| Cash from Operations | -2.64M | -764.10K | -3.63M | -2.67M | -1.76M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.54M | 1.10M | 3.09M | -11.02M | 732.00K |
| Cash from Investing | 2.54M | 1.10M | 3.09M | -11.02M | 732.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 14.00M | -- |
| Repurchase of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | -73.50K |
| Total Dividends Paid | -- | -1.36M | -- | 0.00 | -1.29M |
| Other Financing Activities | -- | -- | 68.10K | 0.00 | -68.10K |
| Cash from Financing | -- | -1.36M | 1.20M | 14.00M | -1.43M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -99.90K | -1.02M | 656.30K | 310.40K | -2.46M |